No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹20.4Prev. Close
₹19.99Turnover(Lac.)
₹1.87Day's High
₹20.4Day's Low
₹19.952 Week's High
₹3052 Week's Low
₹16.1Book Value
₹9.87Face Value
₹10Mkt Cap (₹ Cr.)
34.28P/E
45.43EPS
0.44Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 17.17 | 16.31 | 15.5 | 15.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -0.62 | -1.46 | -2.02 | -2.84 |
Net Worth | 16.55 | 14.85 | 13.48 | 12.66 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 14.53 | 26.42 | 20.09 | 13.98 |
yoy growth (%) | -44.98 | 31.48 | 43.72 | 14.03 |
Raw materials | -11.75 | -23.52 | -18.34 | -12.46 |
As % of sales | 80.87 | 89.02 | 91.3 | 89.15 |
Employee costs | -0.41 | -0.46 | -0.34 | -0.36 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.19 | 0.18 | 0.24 | 0.18 |
Depreciation | -0.22 | -0.27 | -0.1 | -0.13 |
Tax paid | -0.09 | -0.21 | -0.12 | -0.06 |
Working capital | 0.37 | 2.88 | 0.4 | -7.57 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -44.98 | 31.48 | 43.72 | 14.03 |
Op profit growth | -40.79 | 31.2 | -388.5 | -67.98 |
EBIT growth | -13.81 | -2.85 | 12.77 | 1,144.77 |
Net profit growth | -399.48 | -126.14 | 5.66 | -67.83 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,882.15 | 103.47 | 4,51,590.83 | 705.44 | 0.85 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,912.75 | 71.33 | 1,83,511.79 | 598 | 0.43 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,457.15 | 67.54 | 1,50,850.21 | 577 | 0.13 | 2,547 | 249.82 |
Cipla Ltd CIPLA | 1,409.8 | 30.77 | 1,13,883.72 | 384.64 | 0.92 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,333.95 | 34.58 | 1,11,339.07 | -219.4 | 0.6 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Jay Kothari
Executive Director
Anju Kothari
Independent Non Exe. Director
Pooja Bhandari
Independent Non Exe. Director
Athak Mahajan
Independent Non Exe. Director
Rajiv Kumar
Company Sec. & Compli. Officer
Arpita Vijayvargiya
01 Panjon Farm House,
Airport Bijasan Road,
Madhya Pradesh - 452005
Tel: -
Website: http://www.panjon.in
Email: bse@panjon.in; info@panjon.in
D-153/A 1st Flr,
Okhla Industrial Are, Phase-I,
New Delhi-110020
Tel: 011 - 26812682 / 83
Website: www.skylinerta.com
Email: admin@skylinerta.com
Summary
Panjon Limited was incorporated on 28 March, 1990 as Panjon Private Limited and subsequently converted into a public limited company on November 7, 1992. Initially, the Company engaged in the manufact...
Read More
Reports by Panjon Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.